Vaccination with a live retrovirus: the nature of the protective immune response.
AUTOR(ES)
Ruprecht, R M
RESUMO
We tested 3'-azido-3'-deoxythymidine (zidovudine) combined with interferon alpha as chemoprophylaxis after exposing mice to Rauscher murine leukemia virus. Therapy started 4 hr after inoculation and administered for 20 days prevented viremia and disease in all 234 mice tested. When the animals were rechallenged with live virus after cessation of therapy, 96% were resistant. The nature of this protective immune response was analyzed: Passive serotherapy of naive mice challenged subsequently with Rauscher murine leukemia virus was only protective at a high dose of immune serum. Immune, but not naive, T cells alone were fully protective against virus challenge. We conclude that vaccination with a live retrovirus that cannot replicate because of pharmacological blockade induces a T-cell response capable of protecting against a lethal retrovirus-induced disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=54364Documentos Relacionados
- Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.
- Vaccination with Calpain Induces a Th1-Biased Protective Immune Response against Schistosoma japonicum
- Immune Response to Vaccination with a Live Influenza Virus (H3N2) Vaccine (“Ann” Strain)
- Kinetics of the Development of Protective Immunity in Mice Vaccinated with a Live Attenuated Retrovirus
- Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.
